Age-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticles
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Age-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticles ; volume:11 ; number:1 ; day:23 ; month:9 ; year:2013 ; pages:1-12 ; date:12.2013
Journal of nanobiotechnology ; 11, Heft 1 (23.9.2013), 1-12, 12.2013
- Creator
-
Glat, Micaela
- Contributor
-
Skaat, Hadas
Menkes-Caspi, Noa
Margel, Shlomo
Stern, Edward A.
SpringerLink (Online service)
- DOI
-
10.1186/1477-3155-11-32
- URN
-
urn:nbn:de:1111-2016073040240
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Glat, Micaela
- Skaat, Hadas
- Menkes-Caspi, Noa
- Margel, Shlomo
- Stern, Edward A.
- SpringerLink (Online service)
Other Objects (12)
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neuropathology of the Alzheimer's continuum: an update
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neuropathology of the Alzheimer's continuum: an update
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neuropathology of the Alzheimer's continuum: an update
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology